Case number 1:23-cv-01103
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 3, 2024 | 53 | JOINT Claim Construction Chart, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Chart 1, # 2 Exhibit A, # 3 Exhibit B part 1, # 4 Exhibit B part 2, # 5 Exhibit B part 3, # 6 Exhibit B part 4)(Fahnestock, Derek) Modified on 7/3/2024 (nms). (Entered: 07/03/2024) (0) |
| Jun 21, 2024 | 52 | SO ORDERED Granting (D.I. 51 in 23-cv-1103-RGA; D.I. 274 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Claim Construction Deadlines (*Reset Deadlines: Joint Claim Construction Brief due by 9/18/2024). Signed by Judge Richard G. Andrews on 6/21/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 06/21/2024) (2) |
| Jun 20, 2024 | 51 | STIPULATION and Proposed Order to Extend Claim Construction Deadlines - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 6/21/2024 (nms). (Entered: 06/20/2024) (2) |
| Jun 20, 2024 | 50 | ORAL ORDER: At the request of the parties and due to religious observances the Markman Hearing scheduled for 10/3/2024, is CANCELED. The Markman hearing is now rescheduled for 10/11/2024, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 6/20/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 06/20/2024) (0) |
| May 28, 2024 | N/A | CORRECTING ENTRY: The Notice of Service (D.I. 271 in 21md3017-RGA; D.I. 50 in 23cv1103-RGA) filed on 5/24/2024, has been removed as it was duplicative of a a notice of service already on the docket. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 05/28/2024) (0) |
| May 24, 2024 | 49 | NOTICE OF SERVICE of Plaintiffs' Proposed Claim Terms for Construction - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 05/24/2024) (4) |
| May 3, 2024 | 48 | NOTICE OF SERVICE of Defendant and Counterclaimant Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.s Initial Invalidity Contentions and Initial Invalidity Contentions Exhibits filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 05/03/2024) (3) |
| Apr 29, 2024 | 47 | SO ORDERED Granting (D.I. 259 in 21-md-03017-RGA-LDH; D.I. 46 in 23-cv-01103-RGA) Stipulation and Proposed Order correcting defendant name. Signed by Judge Richard G. Andrews on 4/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 04/29/2024) (3) |
| Apr 29, 2024 | 46 | STIPULATION and [Proposed] Order to Correct Case Caption - by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 04/29/2024) (3) |
| Apr 5, 2024 | 45 | NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Auson's NDA Products - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 04/05/2024) (4) |
| Mar 25, 2024 | 44 | NOTICE OF SERVICE of (1) Bayer Intellectual Property GmbH, Bayer Pharma AG, and Bayer AG's Responses and Objections to Defendants' First Set of Requests for Production to Plaintiffs; (2) Bayer Intellectual Property GmbH, Bayer Pharma AG, and Bayer AG's Responses and Objections to Defendants' First Set of Interrogatories to Plaintiffs; (3) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Requests for Production to Plaintiffs; and (4) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Interrogatories to Plaintiffs - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 03/25/2024) (4) |
| Mar 22, 2024 | N/A | Pro Hac Vice Attorney Jonathan J. Madara for Auson Pharmaceuticals Co., Ltd. and Auson Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 03/22/2024) (0) |
| Mar 22, 2024 | N/A | SO ORDERED, re 42 MOTION for Pro Hac Vice Appearance of Attorney Jonathan J. Madara, filed by Auson Pharmaceuticals, Inc., Auson Pharmaceuticals Co., Ltd.. Signed by Judge Richard G. Andrews on 3/22/2024. (nms) (Entered: 03/22/2024) (0) |
| Mar 22, 2024 | 43 | Pro Hac Vice Fee - Credit Card Payment received for Jonathan J. Madara. ( re 42 MOTION for Pro Hac Vice Appearance of Attorney Jonathan J. Madara )( Payment of $ 50, receipt number ADEDC-4368243).(DeSantis, Kasey) (Entered: 03/22/2024) (0) |
| Mar 21, 2024 | 42 | MOTION for Pro Hac Vice Appearance of Attorney Jonathan J. Madara - filed by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc.. (DeSantis, Kasey) (Entered: 03/21/2024) (3) |
| Mar 14, 2024 | 41 | NOTICE OF SERVICE of Defendant and Counterclaimant Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.s Objections and Responses to Plaintiffs' Discovery Requests re 29 Notice of Service, filed by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc..(DeSantis, Kasey) (Entered: 03/14/2024) (3) |
| Mar 8, 2024 | 40 | Joint Status Report Regarding Stay, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/11/2024 (nms). (Entered: 03/08/2024) (5) |
| Mar 8, 2024 | 39 | NOTICE OF SERVICE of Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd.s samples and core technical documents filed by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc..(DeSantis, Kasey) (Entered: 03/08/2024) (3) |
| Mar 6, 2024 | 38 | SO ORDERED Granting Stipulated Protective Order (D.I. 37 in 23-cv-1103-RGA; D.I. 241 in 21-md-3017-RGA-LDH). Signed by Judge Richard G. Andrews on 3/6/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 03/06/2024) (30) |
| Mar 6, 2024 | 37 | PROPOSED Stipulated Protective Order, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 3/6/2024 (nms). (Entered: 03/06/2024) (30) |
| Feb 27, 2024 | 36 | NOTICE OF SERVICE of (i) Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (ii) Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.s Initial Disclosures Identifying Custodians and Non-Custodial Sources filed by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc..(DeSantis, Kasey) (Entered: 02/27/2024) (3) |
| Feb 27, 2024 | 35 | NOTICE OF SERVICE of (1) Bayer Intellectual Property GmbH, Bayer Pharma AG, and Bayer AG's Initial Disclosures; (2) Bayer Intellectual Property GmbH, Bayer Pharma AG, and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery; (3) Janssen Pharmaceuticals, Inc.'s Initial Disclosures; and (4) Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delaware's Default Standard for Discovery - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 02/27/2024) (4) |
| Feb 26, 2024 | 34 | NOTICE of Service of Defendants' First Set of Requests for Production (No. 1-80) and First Set of Interrogatories (Nos. 1-7) on Plaintiffs Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc. by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc. (DeSantis, Kasey) (Entered: 02/26/2024) (3) |
| Feb 20, 2024 | N/A | SO ORDERED, re (D.I. 32 in 23-cv-1103-RGA; D.I. 226 in 21-md-3017-RGA-LDH) MOTION for Pro Hac Vice Appearance of Attorney Richard Hildreth III and Dana B. Kinel, filed by Bayer Pharma AG, Bayer AG, Bayer Intellectual Property GMBH. Signed by Judge Richard G. Andrews on 2/20/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 02/20/2024) (0) |
| Feb 16, 2024 | 33 | Pro Hac Vice Fee - Credit Card Payment received for Richard Hildreth III and Dana B. Kinel. ( re 32 MOTION for Pro Hac Vice Appearance of Attorney Richard Hildreth III and Dana B. Kinel )( Payment of $ 100, receipt number ADEDC-4341249).(Fahnestock, Derek) (Entered: 02/16/2024) (0) |
| Feb 16, 2024 | 32 | MOTION for Pro Hac Vice Appearance of Attorney Richard Hildreth III and Dana B. Kinel - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG. (Fahnestock, Derek) (Entered: 02/16/2024) (6) |
| Feb 16, 2024 | N/A | SO ORDERED, re (D.I. 30 in 23-cv-1103-RGA; D.I. 224 in 1:21-md-3017-RGA-LDH) MOTION for Pro Hac Vice Appearance of Attorney Ben Picozzi, filed by Bayer Pharma AG, Bayer AG, Bayer Intellectual Property GMBH. Signed by Judge Richard G. Andrews on 2/16/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 02/16/2024) (0) |
| Feb 16, 2024 | 31 | Pro Hac Vice Fee - Credit Card Payment received for Ben Picozzi. ( re 30 MOTION for Pro Hac Vice Appearance of Attorney Ben Picozzi )( Payment of $ 50, receipt number ADEDC-4341129).(Fahnestock, Derek) (Entered: 02/16/2024) (0) |
| Feb 16, 2024 | 30 | MOTION for Pro Hac Vice Appearance of Attorney Ben Picozzi - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG. (Fahnestock, Derek) (Entered: 02/16/2024) (4) |
| Feb 14, 2024 | 29 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Defendants Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd.; and (2) Plaintiffs' First Set of Interrogatories to Defendants Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd. - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Smith, Rodger) (Entered: 02/14/2024) (4) |
| Feb 12, 2024 | 28 | SCHEDULING ORDER: Joinder of Parties due by 8/23/2024. Amended Pleadings due by 8/23/2024. Fact Discovery completed by 11/1/2024. Joint Claim Construction Brief due by 9/11/2024. A Markman Hearing is set for 10/3/2024, at 9:30 AM in Courtroom 6A. Within seven days of March 14, 2025, the parties shall submit a Joint Status Report to the Court addressing remand of the action to the District of New Jersey for trial proceedings (see Order for further details). Signed by Judge Richard G. Andrews on 2/12/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 02/12/2024) (10) |
| Feb 9, 2024 | 27 | NOTICE OF SERVICE of Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 02/09/2024) (4) |
| Feb 6, 2024 | 26 | PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 2/6/2024 (nms). (Entered: 02/06/2024) (0) |
| Feb 6, 2024 | 25 | Answer to Complaint and Counterclaims of Defendants Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd., filed by Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 2/6/2024 (nms). (Entered: 02/06/2024) (11) |
| Dec 21, 2023 | 24 | ORAL ORDER: The Stay as to the '218 patent is LIFTED. The parties should propose a schedule that results in remand of at least the '218 patent to New Jersey so that the case is ready to be tried before October 2025. Ordered by Judge Richard G. Andrews on 12/21/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 12/21/2023) (0) |
| Dec 15, 2023 | 23 | Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock regarding, status. (Fahnestock, Derek) Modified on 12/18/2023 (nms). (Entered: 12/15/2023) (3) |
| Nov 13, 2023 | 22 | Letter to The Honorable Richard G. Andrews, from Kasey H. DeSantis, regarding status. (DeSantis, Kasey) Modified on 11/13/2023 (nms). (Entered: 11/13/2023) (1) |
| Nov 10, 2023 | 21 | NOTICE of Appearance by Kasey Hacker DeSantis on behalf of Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc. (DeSantis, Kasey) (Entered: 11/10/2023) (2) |
| Nov 9, 2023 | 20 | ORAL ORDER: A joint status letter regarding the entry of appearance of local counsel for Defendants is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 11/9/2023. (nms) (Entered: 11/09/2023) (0) |
| Oct 13, 2023 | 19 | ANSWER to 10 Answer to Complaint, and Counterclaim, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) Modified on 11/9/2023 (nms). (Entered: 10/13/2023) (11) |
| Oct 10, 2023 | N/A | Pro Hac Vice Attorney Howard S. Suh for Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 10/10/2023) (0) |
| Oct 5, 2023 | N/A | Remark: MDL panel has been advised (jfm) (Entered: 10/05/2023) (0) |
| Oct 5, 2023 | 18 | Record of case transferred in from District of New Jersey; Case Number in Other District: 2:23-cv-03020. Copy of Docket Sheet and original file (Entered: 10/05/2023) (0) |
| Oct 5, 2023 | 17 | Order of MDL Panel transferring case to the District of District of Delaware. (krg) [Transferred from New Jersey on 10/5/2023.] (Entered: 10/05/2023) (3) |
| Oct 3, 2023 | N/A | Pro Hac Vice counsel, HOWARD S. SUH, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (mxw, ) [Transferred from New Jersey on 10/5/2023.] (Entered: 10/03/2023) (0) |
| Oct 2, 2023 | 16 | Notice of Request by Pro Hac Vice HOWARD S. SUH to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14754001.) (KALISH, PAUL) [Transferred from New Jersey on 10/5/2023.] (Entered: 10/02/2023) (2) |
| Sep 29, 2023 | 15 | ORDER granting Defendants' 12 Application for Howard S. Suh, Esq. to appear pro hac vice. Signed by Magistrate Judge Leda D. Wettre on 9/29/2023. (mxw) [Transferred from New Jersey on 10/5/2023.] (Entered: 09/29/2023) (3) |
| Sep 28, 2023 | 14 | NOTICE of Appearance by JONATHAN R. LAGARENNE on behalf of AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC. (LAGARENNE, JONATHAN) [Transferred from New Jersey on 10/5/2023.] (Entered: 09/28/2023) (2) |
| Sep 28, 2023 | 13 | NOTICE of Appearance by GERARD P. NORTON on behalf of AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC. (NORTON, GERARD) [Transferred from New Jersey on 10/5/2023.] (Entered: 09/28/2023) (2) |
| Sep 28, 2023 | 12 | APPLICATION/PETITION by AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC.. (Attachments: # 1 Declaration of Howard S. Suh in Support of Pro Hac Vice Admission, # 2 Certification of Paul W. Kalish in Support of Pro Hac Vice Admission, # 3 Text of Proposed Order on Consent Granting Pro Hac Vice Application)(KALISH, PAUL) Modified on 9/28/2023 (mxw). [Transferred from New Jersey on 10/5/2023.] (Entered: 09/28/2023) (0) |
| Sep 22, 2023 | 11 | Corporate Disclosure Statement by AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC. identifying SHANGHAI AUSON PHARMACEUTICALS CO., LTD as Corporate Parent.. (KALISH, PAUL) [Transferred from New Jersey on 10/5/2023.] (Entered: 09/22/2023) (3) |
| Sep 22, 2023 | 10 | ANSWER to 1 Complaint with Affirmative Defenses COUNTERCLAIMS against Bayer Ag, Bayer Intellectual Property Gmbh, Bayer Pharma Ag, Janssen Pharmaceuticals, Inc., by AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A)(KALISH, PAUL) [Transferred from New Jersey on 10/5/2023.] Modified on 10/11/2023 (nms). (Entered: 09/22/2023) (0) |
| Sep 21, 2023 | 9 | NOTICE of Appearance by PAUL W. KALISH on behalf of AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC. (KALISH, PAUL) [Transferred from New Jersey on 10/5/2023.] (Entered: 09/21/2023) (2) |
| Aug 17, 2023 | 8 | NOTICE that pursuant to the order of the United States Judicial Panel on Multidistrict Litigation filed on August 11, 2023, a hearing session has been scheduled to consider various matters under 28 U.S.C. § 1407 on September 28, 2023 at the University of Kentucky (see Section B of attached notice). (krg, ) [Transferred from New Jersey on 10/5/2023.] (Entered: 08/17/2023) (10) |
| Jul 26, 2023 | 7 | WAIVER OF SERVICE Returned Executed by JANSSEN PHARMACEUTICALS, INC., BAYER INTELLECTUAL PROPERTY GMBH, BAYER AG, BAYER PHARMA AG. AUSON PHARMACEUTICALS INC. waiver sent on 7/24/2023, answer due 9/22/2023. (MILLER, KEITH) [Transferred from New Jersey on 10/5/2023.] (Entered: 07/26/2023) (1) |
| Jul 26, 2023 | 6 | WAIVER OF SERVICE Returned Executed by JANSSEN PHARMACEUTICALS, INC., BAYER INTELLECTUAL PROPERTY GMBH, BAYER AG, BAYER PHARMA AG. AUSON PHARMACEUTICALS CO., LTD. waiver sent on 7/24/2023, answer due 9/22/2023. (MILLER, KEITH) [Transferred from New Jersey on 10/5/2023.] (Entered: 07/26/2023) (1) |
| Jun 5, 2023 | 5 | Corporate Disclosure Statement by BAYER AG, BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG identifying BAYER AG as Corporate Parent.. (MILLER, KEITH) [Transferred from New Jersey on 10/5/2023.] (Entered: 06/05/2023) (2) |
| Jun 5, 2023 | 4 | Corporate Disclosure Statement by JANSSEN PHARMACEUTICALS, INC. identifying JOHNSON & JOHNSON as Corporate Parent.. (MILLER, KEITH) [Transferred from New Jersey on 10/5/2023.] (Entered: 06/05/2023) (2) |
| Jun 2, 2023 | 3 | SUMMONS ISSUED as to AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mxw, ) [Transferred from New Jersey on 10/5/2023.] (Entered: 06/02/2023) (2) |
| Jun 2, 2023 | 2 | AO120 Patent/Trademark Form filed. (Attachments: # 1 Complaint) (mxw) [Transferred from New Jersey on 10/5/2023.] (Entered: 06/02/2023) (0) |
| Jun 1, 2023 | N/A | Case Assigned to Judge Evelyn Padin and Magistrate Judge Leda D. Wettre. (ak, ) [Transferred from New Jersey on 10/5/2023.] (Entered: 06/02/2023) (0) |
| Jun 1, 2023 | 1 | COMPLAINT against Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals Inc. (Filing and Admin fee $ 402 receipt number ANJDC-14359713), filed by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH, Bayer AG, Bayer Pharma AG. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A, # 3 Exhibit B)(MILLER, KEITH) [Transferred from New Jersey on 10/5/2023.] Modified on 10/19/2023 (nms). (Entered: 06/01/2023) (0) |
